This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Copaifera langsdorffii
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
A South American tree producing an oleoresin rich in beta-caryophyllene, a cannabinoid receptor agonist, used for inflammation and pain.
A South American tree producing an oleoresin rich in beta-caryophyllene, a cannabinoid receptor agonist, used for inflammation and pain. Key active compounds include Beta-caryophyllene, Copalic acid, Kaurenoic acid.
Beta-caryophyllene, along with Copalic acid and Kaurenoic acid, are the primary bioactive compounds in Copaiba. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth, acts on pain pathways via anti-inflammatory and neuroactive effects.
CB2 receptor agonist (anti-inflammatory)
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antimicrobial
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Wound healing
Analgesic
Urinary infections
Based on traditional use; clinical evidence limited
Respiratory infections
Based on traditional use; clinical evidence limited
Pain relief
Based on traditional use; clinical evidence limited
Found an error or have a correction for Copaiba?
Report an Issue →